Adiponectin and Breast Cancer Risk
Christos S. Mantzoros1,2, Eleni Petridou3,4, Nick Dessypris4, Charilaos Chavelas4, Μaria Dalamaga4, Delia Marina Alexe4, Yannis Papadiamantis5, Christos Markopoulos6,2, Evangelos Spanos6, George P. Chrousos7,8, Dimitrios Trichopoulos3,4
1Breast Unit, Second Department of Propedeutic Surgery, Athens University Medical School (C.M.), Athens 11527, Greece
2Division of Endocrinology and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center (C.M.), Boston, Massachusetts 02215
3Department of Epidemiology, Harvard School of Public Health (E.P., D.T.), Boston, Massachusetts 02115
4Department of Hygiene and Epidemiology, Athens University Medical School (E.P., N.D., C.C., M.D., D.M.A., D.T.), Athens 11527, Greece
5Elena Venizelou Hospital (Y.P.), Athens 11521, Greece
6BIOMED, International Diagnostic Center (E.S.), Athens 11528, Greece
7First Department of Pediatrics, Ag. Sophia Children’s Hospital, Athens University Medical School (G.C.), Athens 11527, Greece
8Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health (G.C.), Bethesda, Maryland 20892
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Journal of Clinical Endocrinology and Metabolism
Tập 89 Số 3
1102-1107
Thông tin tác giả